Benjamin L. Palleiko, CEO: KalVista Pharmaceuticals KALV Sell · Filed 05/26

Trade details

Type: Insider sale
Amount: $292,598.28
Shares · price: 10,926 sh · $26.78 a share
Held after: 479,989 sh
Stock: KalVista Pharmaceuticals KALV
Person: Benjamin L. PalleikoCEO
Trade date: 26/05/22
Filed: 26/05/26
Days to filing: 4 days

Sold 2.2% of holdings

Share of holding sold: 2.2%

KalVista Pharmaceuticals trades, last 26 weeks

What else happened in KalVista Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 04/22~06/21

Benjamin L. Palleiko's recent trades

Benjamin L. PalleikoCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$30.2K
1,129 sh
$30.2K
Filed 05/19
Traded 05/18
Benjamin L. PalleikoCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$88.7K
3,322 sh
$88.7K
Filed 05/13
Traded 05/12
Benjamin L. PalleikoCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$193.1K
9,550 sh
$193.1K
Filed 04/20
Traded 04/17
Benjamin L. PalleikoCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$107.6K
6,693 sh
$107.6K
Filed 03/10
Traded 03/09
Benjamin L. PalleikoCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$156.2K
10,034 sh
$156.2K
Filed 02/24
Traded 02/23

Benjamin L. Palleiko, CEO — sold $292.6K of KalVista Pharmaceuticals KALV · 2.2% of holdings | Whalegun